Premier Health of America Announces Grant of Management Cease Trade Order

Executive Summary

• The Autorité des marchés financiers has granted a Management Cease Trade Order (MCTO) to Premier Health of America Inc. due to the failure to file its unaudited interim financial statements and MD&A for Q1 2026 by the June 1, 2026 deadline.
• The MCTO restricts trading activities for the Interim CEO, Interim CFO, and Board of Directors until the outstanding filings are submitted, while public trading remains unaffected.
• The company is currently in default under its credit facilities, with no new forbearance agreement being negotiated, and is actively assessing its available strategic and financial options.

Key Details

• Regulatory Action: Management Cease Trade Order (MCTO) issued under National Policy 12-203 by the Autorité des marchés financiers.
• Missing Filings: Unaudited interim financial statements and related Management’s Discussion & Analysis (MD&A) for the quarter ended March 31, 2026.
• Filing Timeline: Original deadline was June 1, 2026; company expects to file on or before June 30, 2026.
• Trading Restrictions: Prohibits insiders (Interim CEO, Interim CFO, and Board members) from trading company securities while filings remain outstanding.
• Public Market Impact: Does not restrict trading by non-insiders or public investors.
• Compliance Protocol: Company will issue bi-weekly default status reports via press release throughout the MCTO period per National Policy 12-203 guidelines.
• Credit Facility Status: Company is currently in default under its existing credit facilities.
• Forbearance & Strategy: No new forbearance agreement is currently being negotiated; management continues to assess all available options to address the default and filing obligations.